Skip to content

REFLECT SCIENTIFIC, INC.: 10-Q filed 2024-11-12

What REFLECT SCIENTIFIC, INC. reported in its quarterly report filed 2024-11-12 (fiscal Q3 2024): 36 published measures, 110 facts as tagged in accession 0001548123-24-000126.

This filing

Form
10-Q (quarterly report)
Filed
2024-11-12
Fiscal period
fiscal Q3 2024
Accession
0001548123-24-000126 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All REFLECT SCIENTIFIC, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-09-302,338,066USD
At 2023-12-312,668,903USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-09-30258,546USD
At 2023-12-31776,329USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-09-302,079,520USD
At 2024-06-301,969,590USD
At 2024-03-311,860,603USD
At 2023-12-311,892,574USD
At 2023-09-302,074,564USD
At 2023-06-301,981,425USD
At 2023-03-312,155,638USD
At 2022-12-312,296,602USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-09-301,030,408USD
At 2023-12-311,277,951USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-07-01 to 2024-09-30109,930USD92
2024-01-01 to 2024-09-30186,946USD274
2024-04-01 to 2024-06-30108,987USD91
2024-01-01 to 2024-03-31-31,971USD91
2023-07-01 to 2023-09-3086,264USD92
2023-01-01 to 2023-09-30-242,663USD273
2023-04-01 to 2023-06-30-181,088USD91
2023-01-01 to 2023-03-31-147,839USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-247,543USD274
2023-01-01 to 2023-09-30-42,481USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-07-01 to 2024-09-30514,023USD92
2024-01-01 to 2024-09-301,532,849USD274
2023-07-01 to 2023-09-30525,874USD92
2023-01-01 to 2023-09-30891,385USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-09-30-19,079,801USD
At 2023-12-31-19,266,747USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-07-01 to 2024-09-3085,664,086shares92
2024-01-01 to 2024-09-3085,664,086shares274
2023-07-01 to 2023-09-3085,214,086shares92
2023-01-01 to 2023-09-3085,214,086shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-07-01 to 2024-09-3085,664,086shares92
2024-01-01 to 2024-09-3085,664,086shares274
2023-07-01 to 2023-09-3085,664,086shares92
2023-01-01 to 2023-09-3085,214,086shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-07-01 to 2024-09-300USD/shares92
2024-01-01 to 2024-09-300USD/shares274
2023-07-01 to 2023-09-300USD/shares92
2023-01-01 to 2023-09-300USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-07-01 to 2024-09-300USD/shares92
2024-01-01 to 2024-09-300USD/shares274
2023-07-01 to 2023-09-300USD/shares92
2023-01-01 to 2023-09-300USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-07-01 to 2024-09-30100USD92
2024-01-01 to 2024-09-30100USD274
2023-01-01 to 2023-09-30312USD273

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-01-01 to 2023-09-3020,625USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-07-01 to 2024-09-3099,239USD92
2024-01-01 to 2024-09-30157,078USD274
2023-07-01 to 2023-09-3080,896USD92
2023-01-01 to 2023-09-30-247,719USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-09-302,093,348USD
At 2023-12-312,370,150USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-09-30139,252USD
At 2023-12-31596,366USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2024-09-3060,000USD
At 2023-12-3160,000USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2024-09-30272,098USD
At 2023-12-31108,191USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-07-01 to 2024-09-30228,587USD92
2024-01-01 to 2024-09-30771,094USD274
2023-07-01 to 2023-09-30249,090USD92
2023-01-01 to 2023-09-30765,733USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2024-09-30775,676USD
At 2023-12-31972,293USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-07-01 to 2024-09-30327,826USD92
2024-01-01 to 2024-09-30928,172USD274
2023-07-01 to 2023-09-30329,986USD92
2023-01-01 to 2023-09-30518,014USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-07-01 to 2024-09-303,092USD92
2024-01-01 to 2024-09-3015,072USD274
2023-07-01 to 2023-09-309,082USD92
2023-01-01 to 2023-09-3020,528USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-09-3085,664,086shares
At 2023-12-3185,664,086shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-09-301,030,408USD
At 2023-12-311,277,951USD
At 2023-09-301,339,446USD
At 2022-12-311,381,927USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-09-3020,302,681USD
At 2023-12-3120,302,681USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-09-30181,618USD
At 2023-12-31235,653USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2024-09-30197,359USD
At 2023-12-31242,644USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-09-303,100USD
At 2023-12-313,100USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2024-09-3015,166USD
At 2023-12-3111,715USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-07-01 to 2024-09-30110,030USD92
2024-01-01 to 2024-09-30187,046USD274
2023-07-01 to 2023-09-3086,264USD92
2023-01-01 to 2023-09-30-242,351USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-07-01 to 2024-09-3087,552USD92
2024-01-01 to 2024-09-30327,411USD274
2023-07-01 to 2023-09-3084,331USD92
2023-01-01 to 2023-09-30272,684USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2024-01-01 to 2024-09-3054,035USD274
2023-01-01 to 2023-09-3044,192USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2024-07-01 to 2024-09-3010,791USD92
2024-01-01 to 2024-09-3029,968USD274
2023-07-01 to 2023-09-305,368USD92
2023-01-01 to 2023-09-305,368USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-09-30163,907USD274
2023-01-01 to 2023-09-30-9,147USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-196,617USD274
2023-01-01 to 2023-09-30123,602USD273

Inspect the source

Entity
REFLECT SCIENTIFIC, INC. / CIK 0001103090
Captured
2026-09-20T05:23:12.214Z
SEC response SHA-256
813550c8006e4fa44b9a7a7762a98655bae3a221b94d07ff4c5994f0aef8e605

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001103090.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))